Literature DB >> 7489850

Plasma fibrinogen as cardiovascular risk factor.

L Breimer.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7489850     DOI: 10.1007/bf00400736

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  21 in total

Review 1.  Plasma fibrinogen--an independent cardiovascular risk factor.

Authors:  E Ernst
Journal:  J Intern Med       Date:  1990-06       Impact factor: 8.989

2.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

3.  Ethnic group comparisons of variables associated with ischaemic heart disease.

Authors:  T W Meade; M Brozović; R Chakrabarti; A P Haines; W R North; Y Stirling
Journal:  Br Heart J       Date:  1978-07

4.  Blood fibrinolytic activity, social class and habitual physical activity--I. A study of black and white men in Evans County, Georgia.

Authors:  P Dischinger; H A Tyroler; R McDonagh; C G Hames
Journal:  J Chronic Dis       Date:  1980

5.  Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women.

Authors:  P Vague; I Juhan-Vague; V Chabert; M C Alessi; C Atlan
Journal:  Metabolism       Date:  1989-09       Impact factor: 8.694

6.  Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.

Authors:  J Heinrich; L Balleisen; H Schulte; G Assmann; J van de Loo
Journal:  Arterioscler Thromb       Date:  1994-01

7.  Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden.

Authors:  C Bengtsson; C Björkelund; L Lapidus; L Lissner
Journal:  BMJ       Date:  1993-11-27

8.  Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women.

Authors:  I Stensvold; A Tverdal; P Urdal; S Graff-Iversen
Journal:  BMJ       Date:  1993-11-20

9.  Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease.

Authors:  B O Olofsson; G Dahlén; T K Nilsson
Journal:  Eur Heart J       Date:  1989-01       Impact factor: 29.983

10.  Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans.

Authors:  N Chaturvedi; P M McKeigue; M G Marmot
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.